SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0000950142-24-001548
Filing Date
2024-06-03
Accepted
2024-06-03 20:43:11
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D eh240491006_13d-lappe.htm SC 13D 39002
  Complete submission text file 0000950142-24-001548.txt   40452
Mailing Address 11622 EL CAMINO REAL SUITE 100 SAN DIEGO CA 92130
Business Address
Lappe Mark (Filed by) CIK: 0001366074 (see all company filings)

Type: SC 13D

Mailing Address 11025 N. TORREY PINES ROAD, SUITE 140 LA JOLLA CA 92037
Business Address 11025 N. TORREY PINES ROAD, SUITE 140 LA JOLLA CA 92037 (858) 795-4220
Inhibrx Biosciences, Inc. (Subject) CIK: 0002007919 (see all company filings)

IRS No.: 990613523 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-94527 | Film No.: 241015747
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)